Results 111 to 120 of about 6,563 (227)

Refractory healing after surgical therapy of osteonecrosis of the jaw: associated risk factors in aged patients

, 2019
Ji-Youn Kim,1 Hyun Chul Song,1 Hyeon-Gun Jee21Division of Oral & Maxillofacial Surgery, Department of Dentistry, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; 2Healthcare Innovation ...
Jee HG, Kim JY, Song HC
core  

Bisphosphonate related osteonecrosis of the jaw – Manifestation in a microvascular iliac bone flap

, 2011
Bisphosphonate related osteonecrosis of the jaw (BRONJ) is a side effect that may emerge due to a long-term bisphosphonate therapy. Although the timely diagnosis and initiation of treatment are associated with good outcome results, extended cases require
Kolk, Andreas, Wolff, Klaus-Dietrich, Andreas Kolk, Otto, Sven, Ehrenfeld, Michael, Klaus-Dietrich Wolff, Pautke, Christoph, Simone Reu, Sven Otto, Michael Ehrenfeld, Stephen Stürzenbaum, Christoph Pautke, Reu, Simone, Stuerzenbaum, Stephen   +13 more
core   +2 more sources

Stress response in periodontal ligament stem cells may contribute to bisphosphonate‑associated osteonecrosis of the jaw: A gene expression array analysis. [PDF]

Mol Med Rep, 2020
Shi Y, Li M, Yu Y, Zhou Y, Zhang W, Hua H, Wang S.   +6 more
europepmc   +1 more source

Bone Scintigraphy and SPECT/CT of Bisphosphonate-Induced Osteonecrosis of the Jaw

, 2009
Endovenous bisphosphonate therapy seems associated with os- teonecrosis of the jaw. The aim of this study was to evaluate the additional diagnostic value of hybrid SPECT/CT in 99mTc-methylene diphosphonate 3-phase bone scintigraphy of osteonecrosis of
CAVALLI, FABIO, FILIPPI L, DI LENARDA, Roberto, BIASOTTO, MATTEO, CHIANDUSSI, SILVIA, DORE F   +5 more
core   +1 more source

Relationship Between Osteonecrosis of the Jaw and Bisphosphonate Treatment

, 2010
Terapija bisfosfonatima i njezina etiopatogenetska povezanost s aseptičkom osteonekrozom čeljusti važan je javnozdravstveni problem današnjice.
Ladislav Krapac, Ivana Pavičin, Ivana Savić Pavičin, Keros, Jadranka, Krapac, Ladislav, Badel, Tomislav, Savić Pavičin, Ivana, Jadranka Keros, Tomislav Badel   +8 more
core   +1 more source

Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

Reumatismo, 2011
Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of parenteral bisphosphonate therapy for cancer. Several ONJ cases have been reported in patients taking oral bisphosphonates for osteoporosis or Paget's disease. Even if the number of cases of ONJ in patients taking oral bisphosphonates are still rare compared to the total exposure,
openaire   +4 more sources

Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment.

Medicina oral, patologia oral y cirugia bucal, 2008
5
Bocanegra Pérez, Sacramento, Vicente Barrero, Mario, Sosa Hernández, Manuel, Knezevic, Milan, Castellano Navarro, José María, Rodríguez Millares, José   +5 more
openaire   +3 more sources

Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw

, 2012
Platelet-rich plasma is a concentrate of growth factors and osteoconductive proteins, which can play a major role in bone biology by accelerating and enhancing bone repair and regeneration.
Castellano-Navarro, J. M., Bocanegra-Pérez, S., Ramos-Macías, A., Rodríguez-Millares, J., Knezevic, M., Rodríguez-Bocanegra, E., Pérez-Plasencia, D., Vicente-Barrero, M.   +7 more
core   +1 more source

Jaw Osteonecrosis in Patients Receiving Oral Bisphosphonates Therapy [PDF]

, 2020
We describe the cases of three patients, under the care of the rheumatology service, who presented with osteonecrosis of the jaw whist on oral bisphosphonate therapy.
D Simcox, K Grover, R Godfrey, R Peshin
core  

Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review

Journal of Oral Research
Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but significant adverse event primarily associated with the intake of antiresorptive and antiangiogenic medications.
Rahul Mohandas, Subhashree Mohapatra, Muskaan Singh, Supriya Kheur   +3 more
doaj   +1 more source